Pain is an unpleasant emotional, subjective, and sensory experience due to the actual or potential damage caused to cells or tissues of the patients. Pain is the most common symptom in various manifestations that lead patients to seek medical assistance or advice. Cancer is associated with several well-defined acute as well as chronic pain syndromes. Cancer is a complex and potentially fatal disease that is primarily caused through environmental factors resulting into gene mutations affecting critical cell-regulatory proteins.
Such changes trigger aberrant cell behavior leading to uncontrolled proliferation of cells (tumor formation) and subsequent destruction of surrounding normal tissues. Tumors are either benign or malignant, while the malignant tumors are characterized by rapid growth, invasiveness, and potential to colonize in distant organs. These tumors exert pressure by pressing on nerves, bones, and other parts of the body causing pain. Cancer pain is also experienced during active cancer therapy and primarily during the advanced stages of cancer.
Obtain Report Details @ http://www.transparencymarketresearch.com/cancer-pain-management-market.html
The rising prevalence of cancer across the globe is driving the global cancer diagnostics market. According to the International Agency for Research on Cancer, there were 14.1 million new cases of cancer and 8.2 million deaths recorded globally in 2012. Based on the above statistical information, the World Health Organization (WHO) estimated that by 2025, 19.3 million new cases are expected to occur each year. Rising incidences of cancer and increasing healthcare spending is anticipated to aid the global cancer pain management market. Moreover, the Patient Protection Act and Affordable Care Act amended on March 30, 2010, by the Health Care and Education Reconciliation Act, enhancing the insurance access to more than 25 million U.S. citizens, is eventually estimated to support the growth of cancer pain management.
The pain management methods for cancer used currently, include medication or drugs, nerve blocks, oral morphine therapy, fentanyl patches, and medical systems or devices. Opioids are considered to be the most effective way of pain management, while combined pain management therapies and medication are more effective. The global market for cancer pain management is projected to expand significantly due to advances in technology for better alternatives for pain management and favorable government initiatives and funding. The alarming rise in the rate of cancer prevalence compels healthcare providers to rethink of their goals of treating cancer and also focus on pain management, which is likely to require cancer pain management methods that are specific, efficient, and sensitive.
In terms of regions, the cancer pain management market can be into Asia Pacific (APAC), Europe, Middle East & Africa (MEA), North America (NA), and Latin America (LA). Key players operating in the cancer pain management market include Abbott, Boston Scientific Corporation, Baxter, Medtronic plc., and Olympus. Intense competition is driving acquisition and in-licensing agreements, as companies are striving to expand and diversify their product pipeline. Strategic partnership and alliances are commonplace, as companies are aiming to synergize their programs and develop combination pain management therapies.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453